Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
0.8752
-0.0260 (-2.89%)
Jul 31, 2026, 3:18 PM EDT - Market open
Lucid Diagnostics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 27.88 | 34.71 | 22.36 | 18.9 | 22.47 | 53.66 |
Cash & Short-Term Investments | 27.88 | 34.71 | 22.36 | 18.9 | 22.47 | 53.66 |
Cash Growth | 10.45% | 55.22% | 18.32% | -15.92% | -58.12% | 48238.74% |
Accounts Receivable | 0.69 | 0.64 | 0.05 | 0.05 | 0.02 | 0.2 |
Inventory | 0.47 | 0.35 | 0.34 | 0.28 | 0.11 | - |
Other Current Assets | 2.33 | 1.77 | 2.4 | 2.85 | 1.75 | 3.45 |
Total Current Assets | 31.36 | 37.47 | 25.15 | 22.07 | 24.36 | 57.3 |
Net Property, Plant & Equipment | 2.5 | 2.62 | 3.7 | 2.64 | 3.6 | 0.97 |
Other Intangible Assets | 0.21 | 0.32 | 0.74 | 1.42 | 3.45 | - |
Other Long-Term Assets | 0.01 | 0.05 | 1.13 | 1.13 | 1.11 | 0.73 |
Total Assets | 34.08 | 40.45 | 30.72 | 27.27 | 32.51 | 59 |
Accounts Payable | 1.08 | 0.97 | 1.24 | 1.15 | 1.06 | 1.49 |
Accrued Expenses | 2.2 | 2.72 | 2.83 | 3.84 | 1.45 | 1.11 |
Short-Term Debt | 25.2 | 24 | 18.6 | 13.95 | - | - |
Current Portion of Leases | 0.91 | 0.89 | 0.85 | 1.11 | 0.96 | - |
Other Current Liabilities | - | - | - | 9.34 | 4.96 | 1.66 |
Total Current Liabilities | 29.39 | 28.58 | 23.52 | 29.38 | 8.43 | 4.26 |
Long-Term Leases | 0.7 | 0.93 | 1.8 | 0.2 | 1.04 | - |
Total Long-Term Liabilities | 0.7 | 0.93 | 1.8 | 0.2 | 1.04 | - |
Total Liabilities | 30.08 | 29.51 | 25.32 | 29.58 | 9.46 | 4.26 |
Preferred Stock | 10.13 | 54.27 | 54.42 | 18.63 | - | - |
Common Stock | 0.17 | 0.13 | 0.06 | 0.04 | 0.04 | 0.04 |
Additional Paid-in Capital | 291.66 | 230.87 | 154.68 | 129.76 | 121.08 | 96.61 |
Retained Earnings | -297.96 | -274.34 | -203.77 | -150.74 | -98.08 | -41.9 |
Shareholders' Equity | 4 | 10.94 | 5.39 | -2.31 | 23.05 | 54.74 |
Total Liabilities & Equity | 34.08 | 40.45 | 30.72 | 27.27 | 32.51 | 59 |
Total Debt | 26.8 | 25.82 | 21.25 | 15.26 | 2 | 0 |
Net Cash (Debt) | 1.07 | 8.89 | 1.1 | 3.64 | 20.48 | 53.66 |
Net Cash Growth | - | 704.80% | -69.68% | -82.22% | -61.84% | 48238.74% |
Net Cash Per Share | 0.01 | 0.09 | 0.02 | 0.07 | 0.33 | 2.00 |
Book Value | 4 | 10.94 | 5.39 | -2.31 | 23.05 | 54.74 |
Book Value Per Share | 0.03 | 0.11 | 0.11 | -0.05 | 0.37 | 2.04 |
Tangible Book Value | 3.79 | 10.62 | 4.66 | -3.74 | 19.6 | 54.74 |
Tangible Book Value Per Share | 0.03 | 0.10 | 0.09 | -0.07 | 0.31 | 2.04 |